AGIOS PHARMACEUTICALS, INC. (AGIO) Insider Trading Disclosures
AGIOS PHARMACEUTICALS, INC. (AGIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AGIO
CIK: 1439222
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerHolly Reeves
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-06 | 2026-08-04 | FORM 4 | 0001439222-26-000120 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001950047-26-007592 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0000908834-26-000367 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001439222-26-000118 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001439222-26-000115 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001439222-26-000112 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-02 | — | SCHEDULE 13G Filing | 0001104659-26-080304 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001439222-26-000110 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001439222-26-000108 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000099 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000097 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000095 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000093 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000091 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000089 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000083 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000081 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0001439222-26-000079 | View SEC Doc Filr Page |
| S-8 | 2026-06-18 | — | S-8 | 0001193125-26-275895 | View SEC Doc Filr Page |